• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, May 23, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Several advantages when medical abortion is started at home

by
August 30, 2024
in Health
Reading Time: 3 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Being at home is as safe as at the hospital when a medical abortion after twelve weeks of pregnancy is initiated. These are the findings of a study conducted at the University of Gothenburg. When starting at home, day patient care is usually sufficient, and women are satisfied with the treatment.

Johanna Rydelius

Credit: Photo: University of Gothenburg

Being at home is as safe as at the hospital when a medical abortion after twelve weeks of pregnancy is initiated. These are the findings of a study conducted at the University of Gothenburg. When starting at home, day patient care is usually sufficient, and women are satisfied with the treatment.

In the case of medical abortion up to and including the tenth week of pregnancy, the procedure used is a so-called home abortion. At ten to twelve weeks, day patient care is most commonly used, while s medical abortion after twelve weeks of pregnancy may have a longer course requiring an overnight stay in hospital.

The current study, published in The Lancet, included 457 women in Sweden who were planning to have a medical abortion after 12 weeks of pregnancy. The aim was to investigate the need for hospitalization if treatment was started at home.

About half of the participants were randomly assigned to take the first dose of the abortion medicine misoprostol at home in the morning, two hours before admission to the gynecological hospital ward. Others were randomized to follow the usual healthcare routine and take the first dose after arrival on the ward.

Benefits in the home group

The researchers measured how many people suffered a complication or needed surgical intervention in connection with the abortion. Participants’ pain was assessed repeatedly during treatment, and specific satisfaction surveys were also conducted.

The results show that 71% of those who initiated their abortion at home could be treated as day patients, compared to 46% of those who started in hospital, which is a statistically significant result.

The incidence of severe complications during and after the abortion was low, and the proportion of participants requiring surgical intervention was 6.4% in the home group and 8.5% in the hospital group, confirming previous research in this area.

The majority of study participants were very satisfied with the treatment; 86% in the home group and 81% in the hospital group. However, significantly more people in the home group, 78%, preferred the treatment they were randomized to, compared to 49% in the hospital group.

Economy and autonomy

The researchers assess that a higher proportion of patients would only need day patient care for a medical abortion after 12 weeks of pregnancy if they were offered to take the first dose of misoprostol at home. A change that can bring several benefits.

Johanna Rydelius is a PhD student in obstetrics and gynecology at Sahlgrenska Academy at the University of Gothenburg, a Gynecologist at Sahlgrenska University Hospital and one of the researchers behind the study:

“Providing day patient care for this group of patients could allow countries with limited access to inpatient treatment to expand their abortion care. Day patient care is also potentially less costly for both the healthcare system and the individual patient. Being able to start their own medical treatment at home also promotes patient autonomy,” she says.

The study included Danderyd Hospital, Karolinska University Hospital, Sahlgrenska University Hospital, Södersjukhuset and Örebro University Hospital. The Principal Investigator was Kristina Gemzell Danielsson, Professor at Karolinska Institutet and Gynecologist at Karolinska University Hospital. The treatments in the study were conducted in 2019-2022.



Journal

The Lancet

DOI

10.1016/S0140-6736(24)01079-1

Method of Research

Randomized controlled/clinical trial

Subject of Research

People

Article Title

A Randomized Trial of First dose of Misoprostol Administration at Home or in Hospital for Medical Abortion between 12-22 gestational weeks – The PRIMA (PRIMing At home) Trial

Article Publication Date

29-Aug-2024

Share12Tweet8Share2ShareShareShare2

Related Posts

Boosting Stem Cell-Derived Islet Survival in Hypoxia

Boosting Stem Cell-Derived Islet Survival in Hypoxia

May 23, 2025
Overview of the study exploring the link between sarcopenia and cognitive decline

Muscle Quality: A Potential Early Indicator of Cognitive Decline

May 23, 2025

Parallel Reporter and Transgenic Assays Reveal Neuronal Enhancers

May 23, 2025

Nanovaccine Boosts Personalized Cancer Immunotherapy with Neoantigens

May 23, 2025

POPULAR NEWS

  • Effects of a natural ingredients-based intervention targeting the hallmarks of aging on epigenetic clocks, physical function, and body composition: a single-arm clinical trial

    Natural Supplement Shows Potential to Slow Biological Aging and Enhance Muscle Strength

    91 shares
    Share 36 Tweet 23
  • Analysis of Research Grant Terminations at the National Institutes of Health

    79 shares
    Share 32 Tweet 20
  • Health Octo Tool Links Personalized Health, Aging Rate

    68 shares
    Share 27 Tweet 17
  • Universe Fades Faster Than Expected—Yet Still Over Vast Timescales

    55 shares
    Share 22 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cluster-Root Secretions Enhance Phosphorus Accessibility in Nutrient-Poor Soils

Boosting Stem Cell-Derived Islet Survival in Hypoxia

Assessing Breast Cancer Care Quality in Iran

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.